GW441756 is a potent, selective inhibitor of TrkA (IC50 = 2 nM), with very little activity to c-Raf1 and CDK2.

S49076 is an effective inhibitor of MET, AXL/MER, and FGFR1/2/3.

Genistein is a soy-derived isoflavone and phytoestrogen with antineoplastic activity.

Sapitinib is an erbB receptor tyrosine kinase inhibitor with potential antineoplastic activity.

Tepotinib is an inhibitor of MET tyrosine kinase with potential antineoplastic activity.

Icotinib Hydrochloride is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity.

Dacomitinib is a highly selective, orally bioavailable small-molecule inhibitor of the HER family of tyrosine kinases with potential antineoplastic activity.

Icotinib is a potent and specific EGFR inhibitor with IC50 of 5 nM, including the EGFR, EGFR(L858R), EGFR(L861Q), EGFR(T790M) and EGFR(T790M, L858R).